Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muna I Naash

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Advances in Experimental Medicine and Biology|June 8, 2004
Mouse models of human retinal disease caused by expression of mutant rhodopsin. A valuable tool for the assessment of novel gene therapiesMay Nour, Muna I Naash
Ophthalmic Genetics|December 7, 2006
The role of Rds in outer segment morphogenesis and human retinal diseaseRafal Farjo, Muna I Naash
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 17, 2015
Nanoparticle-based technologies for retinal gene therapyJeffrey Adijanto, Muna I Naash
Progress in Retinal and Eye Research|May 11, 2010
Nanoparticles for retinal gene therapyShannon M Conley, Muna I Naash
Advances in Experimental Medicine and Biology|January 26, 2007
Light/dark translocation of alphatransducin in mouse photoreceptor cells expressing G90D mutant opsinZack A Nash, Muna I Naash
Advances in Experimental Medicine and Biology|January 26, 2007
Transgenic animal studies of human retinal disease caused by mutations in peripherin/rdsXi-Qin Ding, Muna I Naash
Experimental Eye Research|April 16, 2009
Focus on molecules: RDSShannon M Conley, Muna I Naash
Cold Spring Harbor Perspectives in Medicine|August 30, 2014
Gene therapy for PRPH2-associated ocular disease: challenges and prospectsShannon M Conley, Muna I Naash
Investigative Ophthalmology & Visual Science|February 1, 2008
Expression profiling after retinal detachment and reattachment: a possible role for aquaporin-0Rafal Farjo, Ward M Peterson, Muna I Naash
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 7, 2015
Non-viral therapeutic approaches to ocular diseases: An overview and future directionsRahel Zulliger, Shannon M Conley, Muna I Naash
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Advances in Experimental Medicine and Biology|June 8, 2004
Mouse models of human retinal disease caused by expression of mutant rhodopsin. A valuable tool for the assessment of novel gene therapiesMay Nour, Muna I Naash
Ophthalmic Genetics|December 7, 2006
The role of Rds in outer segment morphogenesis and human retinal diseaseRafal Farjo, Muna I Naash
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 17, 2015
Nanoparticle-based technologies for retinal gene therapyJeffrey Adijanto, Muna I Naash
Progress in Retinal and Eye Research|May 11, 2010
Nanoparticles for retinal gene therapyShannon M Conley, Muna I Naash
Advances in Experimental Medicine and Biology|January 26, 2007
Light/dark translocation of alphatransducin in mouse photoreceptor cells expressing G90D mutant opsinZack A Nash, Muna I Naash
Advances in Experimental Medicine and Biology|January 26, 2007
Transgenic animal studies of human retinal disease caused by mutations in peripherin/rdsXi-Qin Ding, Muna I Naash
Experimental Eye Research|April 16, 2009
Focus on molecules: RDSShannon M Conley, Muna I Naash
Cold Spring Harbor Perspectives in Medicine|August 30, 2014
Gene therapy for PRPH2-associated ocular disease: challenges and prospectsShannon M Conley, Muna I Naash
Investigative Ophthalmology & Visual Science|February 1, 2008
Expression profiling after retinal detachment and reattachment: a possible role for aquaporin-0Rafal Farjo, Ward M Peterson, Muna I Naash
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 7, 2015
Non-viral therapeutic approaches to ocular diseases: An overview and future directionsRahel Zulliger, Shannon M Conley, Muna I Naash
Pageof 14